Stephen Palmer
About Stephen Palmer
CSO Stephen Palmer
Stephen Palmer is the Chief Scientific Officer (CSO) with over 30 years of experience in drug discovery and development. He has held executive roles in top global biopharmaceutical companies, contributing significantly to advancements in the pharmaceutical industry.
Stephen Palmer's Drug Discovery and Development Experience
Stephen Palmer boasts over three decades of experience in drug discovery and development. He has been involved in various high-profile projects and has worked with top biopharmaceutical companies to advance their research and development efforts.
Former Global Head of Reproductive Health Research at Merck Group
Stephen Palmer served as the Global Head of Reproductive Health Research at Merck Group. During his tenure, he led several key initiatives, including the spinout of the first orally-available FSH programs from Merck. His expertise in reproductive health research is well recognized in the industry.
Scientific Founder of Acquired Biotech Company
Stephen Palmer was the scientific founder of a biotech company that was subsequently acquired by a public pharmaceutical company. This achievement highlights his significant contributions to the biotech sector and reflects his capability in building valuable scientific enterprises.
Leadership at Baylor's Center for Drug Discovery
At Baylor's Center for Drug Discovery, Stephen Palmer served as an Associate Professor and Director of Lead Discovery and Development. In this role, he led a team focused on innovative approaches in drug discovery, including pioneering new uses of DNA-encoded libraries.